Attorney James J. Martines, Esq. revealed his own personal connection with Zofran in an article published in the Las Vegas Sun. Martines wrote, “When the pediatric cardiologist told me and my wife five years ago that our newborn daughter suffered from atrial defect septal [a hole in the wall between the two upper chambers of the heart], the last question on my mind was whom to blame.”
In the piece, Martines outlines the story of Zofran from its approval by the FDA in 1991 to treat nausea in cancer patients, to its off-label prescribing by doctors for pregnant women to combat morning sickness. Manufacturer GlaxoSmithKline (GSK) admitted in the Toronto Star, the FDA has not approved Zofran for use in pregnant women due to a lack of studies on the potential effects of the drug on pregnant mothers or their unborn children.
“It is up to us to stop more innocent children from being harmed and to help those who already have been harmed,” Martines concludes. Several studies have shown a potential link between Zofran and several types of birth defects including heart defects, heart murmurs and cleft lip/palate defects.